BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 11278454)

  • 1. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
    Chung H ; Derse D
    J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing.
    Gontarek RR; Derse D
    Mol Cell Biol; 1996 May; 16(5):2325-31. PubMed ID: 8628299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
    Liao HJ; Baker CC; Princler GL; Derse D
    Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs.
    Belshan M; Park GS; Bilodeau P; Stoltzfus CM; Carpenter S
    Mol Cell Biol; 2000 May; 20(10):3550-7. PubMed ID: 10779344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
    Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing.
    Martarano L; Stephens R; Rice N; Derse D
    J Virol; 1994 May; 68(5):3102-11. PubMed ID: 8151775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Novel Post-transcriptional Transactivator from the Equine Infectious Anemia Virus.
    Li J; Zhang X; Bai B; Zhang M; Ma W; Lin Y; Wang X; Wang XF
    J Virol; 2022 Dec; 96(24):e0121022. PubMed ID: 36448796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers.
    Zheng ZM; He PJ; Baker CC
    J Virol; 1997 Dec; 71(12):9096-107. PubMed ID: 9371566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential requirements for alternative splicing and nuclear export functions of equine infectious anemia virus Rev protein.
    Harris ME; Gontarek RR; Derse D; Hope TJ
    Mol Cell Biol; 1998 Jul; 18(7):3889-99. PubMed ID: 9632773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
    Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
    J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
    Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
    J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein, p32.
    Tange TO; Jensen TH; Kjems J
    J Biol Chem; 1996 Apr; 271(17):10066-72. PubMed ID: 8626563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational modeling suggests dimerization of equine infectious anemia virus Rev is required for RNA binding.
    Umunnakwe CN; Loyd H; Cornick K; Chavez JR; Dobbs D; Carpenter S
    Retrovirology; 2014 Dec; 11():115. PubMed ID: 25533001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
    Caputi M; Freund M; Kammler S; Asang C; Schaal H
    J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
    Mayeda A; Helfman DM; Krainer AR
    Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rev-mediated nuclear export of RNA is dominant over nuclear retention and is coupled to the Ran-GTPase cycle.
    Fischer U; Pollard VW; Lührmann R; Teufel M; Michael MW; Dreyfuss G; Malim MH
    Nucleic Acids Res; 1999 Nov; 27(21):4128-34. PubMed ID: 10518602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of functional domains of equine infectious anemia virus Rev suggests a bipartite RNA-binding domain.
    Lee JH; Murphy SC; Belshan M; Sparks WO; Wannemuehler Y; Liu S; Hope TJ; Dobbs D; Carpenter S
    J Virol; 2006 Apr; 80(8):3844-52. PubMed ID: 16571801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.